
Trump's Pharma Tariffs Could Increase Drug Prices and Impact Markets
The U.S. plans to impose 100% tariffs on imported branded pharmaceuticals, potentially raising drug prices, but exemptions for generics and U.S.-based manufacturing facilities may limit the impact. Major drugmakers are stockpiling supplies in anticipation, and some European companies expect little to no effect due to existing manufacturing investments and trade agreements.

